Shotsy vs GlucoPal: How These Two GLP-1 Trackers Compare in 2026

Matt Cole, research host, Gila Podcast — edited by Sezen Soykut · Published September 3, 2026

This is informational only, not medical advice.

TL;DR: Shotsy and GlucoPal are both free-to-download GLP-1 dose trackers rated 4.8 stars on the US App Store. Shotsy runs on iPhone and Android, is localised into 17 languages, and reports 1M+ downloads. GlucoPal is iPhone-only — its own guide names Shotsy as a strong Android choice — but adds AI meal-photo and barcode scanning, an animated progress-photo timeline, and a published Pro price of $9.99/mo or $29.99/yr. The account requirement is the detail most comparisons get wrong: neither app needs an account on iPhone, but Shotsy's Android build requires Google Sign-In.

Both names show up in the same searches: "shotsy vs glucopal," "glucopal app," "shotsy android alternative." Fair question — they solve the same core problem with two different bets. Shotsy bet on reach: cross-platform, broadly localised, more brand names named. GlucoPal bet on tightness: iPhone-only, no account at all, a shorter list of features done specifically well. Both are real apps with live listings and genuine four-star-plus followings behind them — this isn't a case of one polished product against an abandoned one, and the right pick genuinely depends on which of those you actually need. Below is a straight, sourced comparison of both — not a scorecard with a declared winner. For the wider field (eight trackers, not two), see our full GLP-1 tracker comparison.

Shotsy vs GlucoPal at a glance

Feature	Shotsy	GlucoPal
Platforms	iPhone + Android	iPhone only (Android "in development")
Minimum iOS version	iOS 18.0 or later	iOS 15.0 or later
US App Store rating	4.8★ (31K ratings)	4.8★ (2.8K ratings)
Self-reported reach	1M+ downloads	100,000+ people
Account required	iPhone: no. Android: yes — Google Sign-In	No
Starting price	Free; in-app purchases from $9.99/mo or $39.99/yr	Free; Pro published at $9.99/mo or $29.99/yr
Dose + injection-site tracking	Yes	Yes
Side-effect logging	Yes	Yes — nausea, fatigue, food noise "and 12 more"
Nutrition logging	Calories, protein, water	Calories, protein, macros via AI photo or barcode scan
Weight tracking	Charts	Trend line through daily fluctuation
Medication-level estimate	Yes	Yes (Pro)
Progress photos	Not described in Shotsy's own materials	Yes, animated from a photo timeline
Data export	PDF	PDF
Compounded meds supported	Yes	Yes
App Store languages	17, incl. Turkish + Spanish	English

Sources: Shotsy, Shotsy privacy policy, Shotsy App Store listing, GlucoPal, GlucoPal privacy policy, GlucoPal App Store listing, GlucoPal's Shotsy alternatives guide — checked September 2026. Ratings, pricing, and platform availability change; confirm on the app's own listing before you decide.

Shotsy: what it is, and who it fits

Shotsy is a free-to-download log for GLP-1 doses, injection sites, side effects, weight, and basic nutrition. Its App Store listing describes tracking "weight, calories, protein, and water intake," and names Ozempic, Wegovy, the Wegovy Pill, Mounjaro, Zepbound, Rybelsus, Saxenda, Victoza, and Trulicity, with support for "multiple simultaneous medications with separate schedules for each" (App Store). Shotsy's own site says it covers both brand-name and compounded options, and adds injection reminders, an injection-site rotation map, progress charts, and PDF export (Shotsy).

What it does well: reach and localisation. It's rated 4.8 stars across 31K US App Store ratings and shipped in 17 languages including Turkish and Spanish (App Store) — genuinely unusual in this category, where English-only is the norm. Its listing also advertises a Maintenance Mode: "Activate a new chart experience when you reach your goal weight," which is a real gap in most trackers, since they're built around active loss and go quiet the moment you stop losing (App Store). And it is the cross-platform option: Shotsy is on Google Play today, which GlucoPal is not (Google Play).

On privacy, Shotsy says "We do not sell your data," and describes iOS entries as stored in your private iCloud database tied to your Apple ID (Shotsy privacy policy).

What to know before you install: the account requirement differs by platform, and this is the thing most comparisons get wrong. Shotsy's privacy policy states "No user account required" on iOS — but on Android it "Requires Google Sign-In," with app data stored in Google Firebase and tied to your account and a platform-generated user ID (Shotsy privacy policy). If a no-login setup is what you're after, that's an iPhone-only property of Shotsy, not an app-wide one. Separately, Shotsy's App Store listing requires iOS 18.0 or later, so older iPhones are out. And Shotsy's own materials don't describe an AI photo-based food scanner or progress photos — nutrition reads as calorie, protein, and water entry.

GlucoPal: what it is, and who it fits

GlucoPal is an iPhone-only tracker built around the same core loop — doses, injection sites, side effects, weight, nutrition — with a few specific bets Shotsy doesn't make. Its site describes AI food logging in one line: "Snap a photo or scan a barcode — AI fills in calories, protein, and macros." It stores progress photos and animates the timeline, frames weight as "Weight trends, not noise" — a trend line through the daily ups and downs rather than a raw daily number — and marks the road with milestones: "Fifteen milestones stand between day one and your goal." Side-effect logging covers "nausea, fatigue, food noise, and 12 more GLP-1-specific symptoms," and exports go out as doctor-ready PDF reports (GlucoPal).

Its published medication list runs wider than Shotsy's at the newer end, naming orforglipron (Foundayo), compounded GLP-1s, and retatrutide — which is investigational and not approved for any use — alongside the standard semaglutide, tirzepatide, liraglutide, and dulaglutide roster (GlucoPal).

What it does well: no account at all, and a price it publishes in plain text rather than hiding behind an install. GlucoPal states "No account required" and says it never asks for your name or email; its privacy policy says data stays on your device and syncs to your personal iCloud via Apple CloudKit, and that GlucoPal doesn't operate the sync servers or have access to the synced data (GlucoPal; GlucoPal privacy policy). Its Pro tier is published in plain text on its own alternatives guide: "GlucoPal Pro ($9.99/mo or $29.99/yr) unlocks the estimated medication-level forecast chart" (GlucoPal). It also runs on iOS 15.0 or later, so it works on older iPhones that Shotsy's iOS 18 floor rules out (App Store).

Credit where it's due on the medication-level chart, too — GlucoPal is unusually careful about its own limits: "Medication-level charts are mathematical estimates based on logged doses and assumed pharmacokinetics. They do not measure the amount of medicine in your blood, predict your personal response, or tell you when to change a dose." (GlucoPal).

What it doesn't do: Android. "GlucoPal is currently available for iPhone. An Android version is in development." (GlucoPal). To its credit, its own guides recommend competitors on that platform rather than pretending the gap isn't there — it calls Shotsy "a strong Android choice for detailed medication schedules, site rotation, estimated levels, nutrition basics, and exports" (GlucoPal) and "the practical pick on Android" (GlucoPal). Its US App Store listing is English-only and carries 2.8K ratings against Shotsy's 31K — a smaller base, and a narrower language reach.

How to choose

If you're on Android, this one's simple — GlucoPal doesn't run there yet, and GlucoPal's own guide names Shotsy as the practical Android pick. Just go in knowing the Android build asks for Google Sign-In. If you're on an older iPhone, GlucoPal's iOS 15 floor may decide it for you: Shotsy needs iOS 18. If you want the longer list of named brand medications, non-English localisation, or Maintenance Mode for life after goal weight, Shotsy is the stronger default. If AI food-photo logging, an animated progress-photo timeline, a genuinely account-free setup, or a subscription price you can read before you install matter more than platform reach, GlucoPal's narrower set of bets is worth going iPhone-only for. And if all you actually need is a simple injection-pen click counter, our free pen click counter does that one job with no install and no account.

Worth naming plainly: both of these are logging tools, and they are honest about that — what you get back is an accurate record of what you did. Turning a pattern across mood, sleep and side effects into a next step is a different question than a tracker answers with numbers alone. It's the gap Gila was built into: less a competing tracker, more a companion for the part that comes after the dose is logged — the habits that need to outlast the prescription. We wrote about what that looks like in practice. Gila is in a free pilot and iPhone-only for now; join the pilot list if that's closer to what you're after than a log.

Frequently asked questions

Is GlucoPal free? It's free to download, with core dose, weight, side-effect, and nutrition logging available at no cost and no account required (GlucoPal). GlucoPal Pro — which unlocks the estimated medication-level forecast chart — is published at $9.99/mo or $29.99/yr (GlucoPal).

Does Shotsy work on Android? Yes. Shotsy is one of the few GLP-1 trackers on both iPhone and Android (Shotsy; Google Play). GlucoPal is iPhone-only.

Is there a GlucoPal alternative for Android users? GlucoPal's own guides point to Shotsy on Android, describing it as "the practical pick on Android" while GlucoPal's Android version remains in development (GlucoPal; GlucoPal).

Which has AI food-photo scanning, Shotsy or GlucoPal? GlucoPal — its site describes photo and barcode scanning that fills in calories, protein, and macros (GlucoPal). We found no equivalent claim in Shotsy's own materials; its nutrition tracking is described as calorie, protein, and water logging (Shotsy; App Store).

Do Shotsy or GlucoPal require an account? It depends on the app and the platform. GlucoPal requires no account (GlucoPal). Shotsy's privacy policy says "No user account required" on iOS, but its Android build "Requires Google Sign-In," with data stored in Google Firebase (Shotsy privacy policy). If going account-free matters to you, check the platform you're actually on.

How do Shotsy and GlucoPal compare to the rest of the category? They're two of dozens of GLP-1 trackers on the market. We looked at eight of the major ones side by side in our full GLP-1 tracker comparison.

Sources

• Shotsy — official site
• Shotsy — privacy policy
• Shotsy GLP-1 Tracker — App Store
• Shotsy — Google Play
• GlucoPal — official site
• GlucoPal — privacy policy
• GlucoPal — best GLP-1 tracker apps guide
• GlucoPal — Shotsy alternatives guide
• GLP-1 Tracker by GlucoPal — App Store
• Gila — full GLP-1 tracker comparison
• Gila — the things a tracker can't measure
• Gila — habits that outlast the prescription
• Gila — free GLP-1 pen click counter

This article is informational only and does not constitute medical advice. Retatrutide is investigational and not approved. Ratings, pricing, and features reflect what Shotsy and GlucoPal state publicly as of September 2026 and are subject to change — verify on each app's own listing. Want more comparisons like this one? Subscribe to our newsletter.